Skip to main content
Toggle navigation
Search
Home
Preview Program
Poster Schedule
Home
Poster Schedule
All Days
Fri, Apr 25
Sat, Apr 26
Poster Schedule
Type here to filter the list
Saturday, April 26, 2025
9:45 AM – 1:15 PM
(71) Race, Ethnicity & Language Differences in Medications for Alcohol Use Disorder Prescribing
Favorite
9:45 AM – 1:15 PM
(72) Racial Differences in LGBTQ+ Substance Use: Insights from All of Us Data
Favorite
9:45 AM – 1:15 PM
(73) Racial Disparities in Mental Health and Substance Use during the COVID-19 Pandemic
Favorite
9:45 AM – 1:15 PM
(74) An OUD Support Line Improves Opioid Use Disorder Treatment in Hospitalized Patients
Favorite
9:45 AM – 1:15 PM
(75) Optimizing Telephone Call Reminders to Improve Appointment Attendance at Outpatient Clinic
Favorite
9:45 AM – 1:15 PM
(76) Facilitators to Patients with Substance Use Disorders Seeking Care in the ED
Favorite
9:45 AM – 1:15 PM
(77) Patient Factors Associated with Hospital Discharge on Buprenorphine Versus Methadone
Favorite
9:45 AM – 1:15 PM
(78) Methadone Dose and Patient-Directed Discharge in Persons with Prior Methadone Enrollment
Favorite
9:45 AM – 1:15 PM
(79) Inpatient OUD Management: Associations with PDD, Readmission, and Mortality
Favorite
9:45 AM – 1:15 PM
(80) Comparative Outcomes of Opioid Withdrawal Management for Patients Admitted with Bacteremia
Favorite
9:45 AM – 1:15 PM
(81) Deep Learning-Based Detection of Xylazine Exposure from Wound Imaging
Favorite
9:45 AM – 1:15 PM
(82) Augmented Reality Technology Engages Opioid Use Disorder Patients in Their Treatment
Favorite
9:45 AM – 1:15 PM
(83) Drug Supply Monitoring: Feedback from People Who Use Drugs
Favorite
9:45 AM – 1:15 PM
(84) Meta-analysis of the Therapeutic Role of TMS and tDCS in Opioid Disorder
Favorite
9:45 AM – 1:15 PM
(85) Alcohol Use Disorder Medication Initiation During Alcohol Withdrawal Hospitalizations
Favorite
9:45 AM – 1:15 PM
(86) Enhancing Viral Hepatitis Harm Reduction through a Comprehensive Addiction Consult Service
Favorite
9:45 AM – 1:15 PM
(87) Sex, Socioeconomic Status, and Self-Perceived Risk of Opioid Overdose
Favorite
9:45 AM – 1:15 PM
(88) Prevalence and Correlates of AUD Diagnoses among Users of HIV Pre-Exposure Prophylaxis
Favorite
9:45 AM – 1:15 PM
(89) Risk Factors of Severe Maternal Morbidity in Individuals with Methamphetamine Use
Favorite
9:45 AM – 1:15 PM
(90) Variation in Toxicology Testing for Substance Exposure In Pregnancy in Michigan Hospitals
Favorite
9:45 AM – 1:15 PM
(91) High Risk and Underserved: Drug and Sexual Patterns Among Women Who Inject
Favorite
9:45 AM – 1:15 PM
(92) Intimate Partner Violence Support in Perinatal Substance Use: Patient and Provider Insights
Favorite
9:45 AM – 1:15 PM
(93) Perceptions of Fertility among Treatment-Seeking Women with Opioid Use Disorder
Favorite
9:45 AM – 1:15 PM
(94) Vascular Changes in the Placentas of Opioid Exposed Pregnancies
Favorite
9:45 AM – 1:15 PM
(95) Perinatal Opioid Use Disorder Program in the Heart of the Opioid Epidemic
Favorite
9:45 AM – 1:15 PM
(96) Perspectives of Pregnant and Postpartum Persons on Xylazine Education and Home Testing
Favorite
9:45 AM – 1:15 PM
(97) Timeouts May Reduce Unnecessary Child Welfare Reports for Substance Exposed Newborns
Favorite
9:45 AM – 1:15 PM
(98) Breaking Barriers: Advancing Addiction Care for Young Immigrant Adults
Favorite
9:45 AM – 1:15 PM
(99) The Kids are Not Alright: Missed Opportunities for Inpatient Adolescent Nicotine Screening
Favorite
9:45 AM – 1:15 PM
(100) Trends in United States Adolescent and Young Adult Overdose Fatalities, 1999-2023
Favorite
9:45 AM – 1:15 PM
(101) Marijuana Exposures and Poisonings of Children Aged 12 and Under
Favorite
9:45 AM – 1:15 PM
(102) Adolescent-Specific Risk and Protective Factors of Substance Use Among High School Students
Favorite
9:45 AM – 1:15 PM
(103) Adolescent and Caregiver Perspective on Substance Use Screening in the Emergency Department
Favorite
9:45 AM – 1:15 PM
(104) Medication Assisted Recovery Anonymous vs 12 Step Groups: Comparing MOUD Stigma Experiences
Favorite
9:45 AM – 1:15 PM
(105) Characteristics Associated with Overdose after Opioid Prescription to Younger Individuals
Favorite
9:45 AM – 1:15 PM
(106) Naloxone and Medication for Opioid Use Disorder in US Emergency Departments
Favorite
9:45 AM – 1:15 PM
(107) Perioperative Buprenorphine Use Protects Against Long-Term Opioid Use
Favorite
9:45 AM – 1:15 PM
(108) Instruments Assessing Long-Term Opioid Therapy for Chronic Pain: A Scoping Review
Favorite
9:45 AM – 1:15 PM
(109) Implementing Revised Methadone Treatment Regulations at NYS Opioid Treatment Programs
Favorite
9:45 AM – 1:15 PM
(110) Expanding Community-Led Partnerships: Residency Integration in a Harm Reduction Clinic
Favorite
9:45 AM – 1:15 PM
(111) People Can Recover: Qualitative Findings from a Statewide Naloxone Distribution Project
Favorite
9:45 AM – 1:15 PM
(112) Retrospective Analysis of Buprenorphine Initiation in an Urban Street Medicine Program
Favorite
9:45 AM – 1:15 PM
(113) Rock Bottom Is Not a Motivator: From Opioid Addiction to Human Flourishing
Favorite
9:45 AM – 1:15 PM
(114) Stigmatizing Language in the Medical Record After Addiction Consult Service Implementation
Favorite
9:45 AM – 1:15 PM
(115) Substance Use Disorder Patient Experience with “Leave Behind Naloxone” in the Community
Favorite
9:45 AM – 1:15 PM
(116) Word of Mouth: The Key to Community Connections and HR Among PWUD
Favorite
9:45 AM – 1:15 PM
(117) Treating Opioid Use Disorder: Perspective of FQHC Clinicians in Los Angeles
Favorite
9:45 AM – 1:15 PM
(118) The UCSF SBIRT Collaborative Care Program for SUD: Design, Development, and Implementation
Favorite
9:45 AM – 1:15 PM
(119) Evaluation of a Family Medicine Contingency Management Program for Substance Use Disorder
Favorite
9:45 AM – 1:15 PM
(120) Advancing Alcohol Use Disorder Treatment Through Clinician Training Program
Favorite
9:45 AM – 1:15 PM
(121) Predictors of Retention During and After Residential Treatment for Substance Use Disorders
Favorite
9:45 AM – 1:15 PM
(122) Prevalent Comorbidities Associated with Substance Use Disorder in East Texas (2021-2024)
Favorite
9:45 AM – 1:15 PM
(123) Heart Transplant Outcomes in Substance Use Disorder: A Nationwide Cohort Study
Favorite
9:45 AM – 1:15 PM
(124) Psychogenic Non-Epileptic Seizures (PNES) in a Case of Alcohol Withdrawal Syndrome
Favorite
9:45 AM – 1:15 PM
(125) Yikes! Methadone To Buprenorphine Transition During Pregnancy, In Jail, Via Telephone
Favorite
9:45 AM – 1:15 PM
(126) Buprenorphine Rescue for XR Naltrexone-Precipitated Opioid Withdrawal: A Case Report
Favorite
9:45 AM – 1:15 PM
(127) Initiating Extended-Release Injectable Buprenorphine in Primary Care without a Test Dose
Favorite
9:45 AM – 1:15 PM
(128) No, No Nootropics! A Case of Tianeptine and Phenibut Withdrawal/Use Disorder
Favorite
9:45 AM – 1:15 PM
(129) Rapid Outpatient Initiation of Long-Acting Injectable Buprenorphine: A Case Series
Favorite
9:45 AM – 1:15 PM
(130) Importance of Collaborative Care for Adolescents with OUD: A Case Report
Favorite
9:45 AM – 1:15 PM
(131) Self-Directed Ketamine Therapy and Withdrawal Syndrome: A Case Report
Favorite
9:45 AM – 1:15 PM
(132) Breaking the Cycle: GLP-1/GIP Agonist Treatment and Alcohol Use Disorder
Favorite
9:45 AM – 1:15 PM
(133) Disulfiram: An Effective Yet Underutilized Drug for AUD
Favorite
9:45 AM – 1:15 PM
(134) Long-Acting Injectable Buprenorphine: A Vein-Saving Victory in Pediatric Case
Favorite
9:45 AM – 1:15 PM
(135) Not Just Fentanyl: Protracted Withdrawal from Para-Fluorofentanyl
Favorite
9:45 AM – 1:15 PM
(136) A Case of Tianeptine Overdose Requiring ICU Admission
Favorite
9:45 AM – 1:15 PM
(137) Years of Life Lost from Stimulant-Involved Cardiovascular Mortality, 2014-2023
Favorite
